Lexaria Bioscience Corp. (LEXX) stock
LEXXNasdaqPharmaceutical PreparationsFiscal year ends August 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày May 31, 2026Last filing: 10-Q on Jul 13, 2026Score 8/30
$4.28+0.10 (+2.39%)
Close on Nov 18, 2026Market cap $106.09MP/E –Yield –
Lexaria Bioscience pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Lexaria Bioscience's pe ratio was 93.9× on Sep 30, 2020, against 73.7× a year earlier. Over the last 2 years it ranged from 73.7× to 266.1×, with a median of 138.9×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2020 | Sep 30, 2020 | 93.9× | −16.4 |
| 2019 | Dec 31, 2019 | 110.3× | −49.4 |
| 2018 | Dec 31, 2018 | 159.7× | – |
See a number that looks wrong?